retatrutide triple agonist obesity trial Experimental drug cut weight by nearly 30% in Phase 3 trials, outperforming approved therapies, Eli Lilly says 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

This came as a surprise to some, especially those who had been trying to conceive unsuccessfully for a while

Could it degrade faster

Alcohol was strange

GLP-1, GIP, exendin-4 and liraglutide had suppressive effects on oxLDL-induced foam cell formation, which is linked with the suppression of infiltrated macrophage foam cells in atherosclerotic plaques, resulting in repressed atherosclerotic plaque formation

It suggests that the benefits in terms of MACE, hospitalization for heart failure, and progression of chronic kidney disease (composite outcome) from SGLT2is occur independently of the use of GLP1-RAs

The exact dose depends on individual response, and finding it requires careful downward titration with monitoring